From: Gait initiation and termination strategies in patients with Prader-Willi syndrome
GAIT INITIATION | |||
---|---|---|---|
PWS | OG | HG | |
DURATION [s] | |||
TAPA1 | 0.45 (0.21)* | 0.44 (0.19) * | 0.32 (0.14) |
TAPA2A | 0.18 (0.08)* | 0.17 (0.07) * | 0.13 (0.08) |
TAPA2B | 0.13 (0.06)* | 0.13 (0.06)* | 0.11 (0.06) |
TLOC | 0.54 (0.11)* | 0.56 (0.11) * | 0.50 (0.08) |
TTOT | 1.34 (0.33)* | 1.35 (0.27)* | 1.09 (0.23) |
VELOCITY [m/s] | |||
VAPA1(x) | 0.05 (0.04)*+ | 0.08 (0.07)* | 0.15 (0.12) |
VAPA2A(x) | 0.07 (0.07)*+ | 0.10 (0.08)* | 0.14 (0.10) |
VAPA2B(x) | 0.09 (0.08)* | 0.12 (0.10)* | 0.18 (0.11) |
VLOC(x) | 0.22 (0.06)*+ | 0.24 (0.10)* | 0.29 (0.10) |
VAPA1(z) | 0.05 (0.05)*+ | 0.09 (0.07) | 0.08 (0.08) |
VAPA2A(z) | 0.29 (0.18)*+ | 0.39 (0.26) | 0.39 (0.24) |
VAPA2B(z) | 0.35 (0.23) | 0.42 (0.20) | 0.39 (0.23) |
VLOC(z) | 0.03 (0.05) | 0.03 (0.03) | 0.02 (0.03) |
LENGTH [mm/m] | |||
LAPA1 | 0.029 (0.010)*+ | 0.041 (0.019) | 0.040 (0.019) |
LAPA2A | 0.037 (0.018)+ | 0.052 (0.029) * | 0.035 (0.019) |
LAPA2B | 0.036 (0.018) | 0.032 (0.026) | 0.028 0.025) |
LLOC | 0.080 (0.011)*+ | 0.093 (0.023) | 0.092 (0.016) |
LTOT | 0.180 (0.035)*+ | 0.216 (0.052)* | 0.192 (0.039) |